Alternatives to Provotics

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Developing engineered biologics to harness the immune system for disease treatment.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

AI-powered platform for antibody discovery and development to create new medicines.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Biotechnology company developing novel immunotherapies for cancer.

Gene therapy company developing transformative treatments for severe genetic diseases.

Gene therapy company developing treatments for rare inherited diseases.

Digital pathology imaging technology and AI-driven precision pathology software.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

Develops a computational model of the human body for drug discovery and development.

Global marketplace connecting researchers with human biospecimens for life science research.

Developing novel radiopharmaceuticals for targeted cancer treatment using advanced molecular imaging and therapy.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

AI-powered spatial biology platform for precision medicine and drug development.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

Develops novel therapeutic antibodies for oncology and autoimmune diseases.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Biopharmaceutical company developing mRNA-based vaccines and therapeutics for infectious diseases and cancer.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

SNIPR Biome is a clinical-stage company developing CRISPR-based therapeutics to precisely target and eliminate specific bacteria in the human microbiome.

AI-powered platform accelerating biological research and drug discovery.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Omega Therapeutics is developing a new class of programmable medicines called Epigenomic Controllers.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.